InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,410.94
(
1.25%
)
US TECH 100
18,398.00
(
1.90%
)
Dow Jones
39,650.64
(
0.75%
)
Brent Oil
80.43
(
-1.45%
)
Bitcoin
59,943.61
(
0.99%
)
Post# of 252867
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 835
Posts 120262
Boards Moderated 18
Alias Born 09/05/2002

DewDiligence

Member Level

Re: DewDiligence post# 130098

Thursday, 12/01/2011 12:02:01 AM

Thursday, December 01, 2011 12:02:01 AM

Post# of 252867
Teva is indeed entering the Lipitor market with Ranbaxy,
but don’t even think of asking about the financial terms.

http://finance.yahoo.com/news/Teva-Announces-Agreement-bw-770819240.html?x=0

›Teva Announces Agreement with Ranbaxy Regarding Generic Lipitor

30-Nov-2011 11:00pm ET

JERUSALEM--(BUSINESS WIRE)-- Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced today that pursuant to an agreement between its subsidiary, Teva Pharmaceuticals USA, Inc. and Ranbaxy Laboratories Limited ("Ranbaxy"), a portion of the profits from Ranbaxy’s sales of Atorvastatin Calcium Tablets during Ranbaxy’s 180-day first-to-file exclusivity period, will be paid to Teva. Terms of the agreement will not be disclosed.‹

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up